Factors influencing treatment recommendations in early-stage Hodgkin's disease: A survey of physicians

Annals of Oncology

Volumn 15, Issue 2, 2004, Pages 261-269

  Ng, A K ^a   Li, S ^b   Neuberg, D ^b   Silver, B ^a   Weeks, J ^b   Mauch, P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Hodgkin's disease; Physician survey; Treatment decision

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CONTROLLED STUDY; EARLY CANCER; EXPERIENCE; FEMALE; HEALTH SURVEY; HODGKIN DISEASE; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL SOCIETY; MEDICAL SPECIALIST; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DECISION MAKING; FEMALE; HEALTH CARE SURVEYS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; PATIENT CARE PLANNING; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL COMPETENCE; PROGNOSIS; RADIATION ONCOLOGY;

EID: 1342310076     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh044     Document Type: Article

References (29)

1. Golomb HM. Management of early-stage Hodgkin's disease: a continuing evolution. Semin Oncol 1998; 25: 476-482.
2. Advani RH, Horning SJ. Treatment of early-stage Hodgkin's disease. Semin Hematol 1999; 36: 270-281.
3. Ng AK, Mauch PM. Controversies in early-stage Hodgkin's disease. Oncology 2002; 16: 588-595, 598 [Discussion 600, 605, 609-618].
4. Hoppe RT, Coleman CN, Cox RS et al. The management of stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. Blood 1982; 59: 455-465.
5. Noordijk EM, Carde P, Mandard AM et al. Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie. Ann Oncol 1994; 5: 107-112.
6. Specht L, Gray RG, Clarke MJ, Peto R. Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3888 patients. International Hodgkin's Disease Collaborative Group. J Clin Oncol 1998; 16: 830-843.
7. Press OW, LeBlanc M, Lichter AS et al. Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease. J Clin Oncol 2001; 19: 4238-4244.
8. Straus D, Yahalom J, Zelenetz A et al. Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs ABVD + radiation therapy for early stage non bulky Hodgkin's disease. The American Society of Hematology 43th Annual Meeting, Orlando, FL, USA 2001; 769a (Abstr 3201).
9. Nachman JB, Sposto R, Herzog P et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002; 20: 3765-3771.
10. Mauch PM, Connors JM, Dosoretz DE et al. American College of Radiology ACR Appropriateness Criteria. Favorable prognosis stage I and II Hodgkin's disease treatment guidelines. http://www.acr.org 1998.
11. Hoppe RT, Abrams RA, Bernstein SH et al. National Comprehensive Cancer Network. Hodgkin's Disease. Version 1. http://www.nccn.org/physician_gls/index.html 2002.
12. Moore MJ, O'Sullivan B, Tannock IF. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1988; 6: 1736-1745.
13. Fowler FJ Jr, McNaughton Collins M, Albertsen PC et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. J Am Med Assoc 2000; 283: 3217-3222.
14. de Jong D, Aleman BM, Taal BG, Boot H. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol 1999; 10: 275-280.
15. Liew KH, Easton D, Horwich A et al. Bulky mediastinal Hodgkin's disease management and prognosis. Hematol Oncol 1984; 2: 45-59.
16. Hughes-Davies L, Tarbell NJ, Coleman CN et al. Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement. Int J Radiat Oncol Biol Phys 1997; 39: 361-369.
17. Aviles A, Delgado S. A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease. Clin Lab Haematol 1998; 20: 95-99.
18. Austin-Seymour MM, Hoppe RT, Cox RS et al. Hodgkin's disease in patients over sixty years old. Ann Intern Med 1984; 100: 13-18.
19. Rossi Ferrini P, Bosi A, Casini C et al. Hodgkin's disease in the elderly: a retrospective clinicopathologic study of 61 patients aged over 60 years. Acta Haematol 1987; 78: 163-170.
20. Bosi A, Ponticelli P, Casini C et al. Clinical data and therapeutic approach in elderly patients with Hodgkin's disease. Haematologica 1989; 74: 463-473.
21. Diaz-Pavon JR, Cabanillas F, Majlis A, Hagemeister FB. Outcome of Hodgkin's disease in elderly patients. Hematol Oncol 1995; 13: 19-27.
22. Weekes CD, Vose JM, Lynch JC et al. Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen. J Clin Oncol 2002; 20: 1087-1093.
23. Yahalom J, Petrek JA, Biddinger PW et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992; 10: 1674-1681.
24. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993; 85: 25-31.
25. Bhatia S, Robison LL, Oberlin O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334: 745-751.
26. Aisenberg AC, Finkelstein DM, Doppke KP et al. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 1997; 79: 1203-1210.
27. Wolden SL, Hancock SL, Carlson RW et al. Management of breast cancer after Hodgkin's disease. J Clin Oncol 2000; 18: 765-772.
28. Cutuli B, Borel C, Dhermain F et al. Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. Radiother Oncol 2001; 59: 247-255.
29. Gurmankin AD, Baron J, Hershey JC, Ubel PA. The role of physicians' recommendations in medical treatment decisions. Med Decis Making 2002; 22: 262-271.